| Active substance |
Peptide |
| Also known as |
HGH Fragment 176-191 |
| Blood pressure |
No significant effects reported |
| Chemical name |
Fragment 176-191 |
| Dosage (medical) |
Not established for medical use |
| Dosage (sports) |
250-500 mcg per day |
| Effects |
Reduces body fat, particularly abdominal fat |
| Formula |
C78H123N23O23S2 |
| Half-life |
Approximately 30 minutes |
| Hepatotoxicity |
None reported |
| Lab Test |
Specialized tests may detect peptide fragments but not commonly included in standard drug panels |
| Main action |
Stimulates lipolysis and inhibits lipogenesis |
| Side effects |
Potential to cause hyperglycemia, headaches, and feelings of lethargy |
| Storage conditions |
Should be stored in a cool, dry place away from light |
| Substance class |
Peptide |
| Trade name |
Not available under any trade names, sold as research chemical |
| Use in sports |
Commonly used in bodybuilding for fat loss |
| Water Retention |
None |
| Active ingredient, mg |
5 |
| Release form |
Vial |
| Manufacturer |
Multi Pharm |
| Packing |
Vial |
